方法对比

	CAGE 问卷	酒精使用障碍识别测试 (AUDIT)	SF-36健康调查问卷
领域	健康测量	健康测量	健康测量
方法族	Process / pipeline	Process / pipeline	Process / pipeline
起源年份	1974	1993	1992
提出者	John A. Ewing and colleagues	World Health Organization (WHO) collaborative group, John Saunders and colleagues	John E. Ware Jr. and Cathy D. Sherbourne
类型	Brief alcohol dependence screening questionnaire	Alcohol use disorder screening and severity assessment	Self-report health status instrument
开创性文献	Ewing, J. A. (1984). Detecting alcoholism: the CAGE questionnaire. JAMA, 252(14), 1905–1907.	Saunders, J. B., Aasland, O. G., Babor, T. F., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption—II. Addiction, 88(6), 791–804.	Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.
别名	CAGE, Cut-Annoyed-Guilty-Eye Opener, Alcohol Dependency Screen	AUDIT, WHO AUDIT, Alcohol Screening	SF-36 Questionnaire, Medical Outcomes Study SF-36
相关	5	5	5
摘要	The CAGE is a 4-item brief alcohol screening questionnaire developed by Ewing and colleagues in the 1970s. The acronym represents the four questions: Cut down, Annoyed, Guilty, Eye opener. Published in 1984, it has become one of the most widely used brief alcohol screens in medical practice due to its simplicity and historical validation.	The Alcohol Use Disorders Identification Test (AUDIT) is a 10-item screening and assessment tool developed by the World Health Organization in 1993. It rapidly identifies hazardous alcohol use, harmful drinking, and alcohol dependence across diverse populations. The AUDIT has become the gold-standard alcohol screening instrument in primary care and clinical settings worldwide.	The SF-36 is a generic, self-administered 36-item questionnaire measuring eight dimensions of health status. Developed by Ware and Sherbourne in 1992, it has become the most widely used health survey in clinical trials, outcomes research, and population health monitoring. It assesses perceived health across physical and mental domains relevant to the general adult population.